IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study

Table 2 Multivariable analysis of factors associated with IgG anti-apoA-1 level in the longitudinal cohort

Variable	Category	Ratio (95% CI)	P value
Anti-La	No	1
	Yes	0.58 (0.39, 0.86)	0.006
Anti-Sm	No	1
	Yes	0.58 (0.43, 0.80)	0.001
Activity in the haematological system	A, B	1
	C, D, E	0.66 (0.53, 0.83)	<0.001
Steroids	≤7.5 mg/day	1
	>7.5 mg/day	1.34 (1.08, 1.66)	0.008

anti-apoA-1, antibodies to apolipoprotein A-1; CI, confidence interval; IgG, immunoglobulin G.

ISSN: 1478-6362